Aurora Cannabis has announced a distribution partnership to broaden access to its medical cannabis products in the Australian market.

The deal, announced on December 17, 2024 is between The Entourage Effect—which provides comprehensive distribution and support services to pharmacies in Australia—and the Aurora subsidiary MedReleaf Australia.

The Entourage Effect will serve as a wholesaler for MedReleaf Australia’s portfolio of products under the CraftPlant, Aurora, and IndiMed brands. Aurora acquired MedReleaf Australia, formerly Indica Industries Pty Ltd, in February 2024.

“We are thrilled to be partnering with MedReleaf Australia to facilitate the distribution and wholesaling of their products,” said Lisa Varley, CEO of The Entourage Effect. “This collaboration marks a significant milestone for both companies, underscoring our shared commitment to improving patient access and advancing the Australian medicinal cannabis market. Together, we are well-positioned to better serve the needs of patients across the nation.”

Andre Jerome, executive vice president of global business development at Aurora, says the deal will help expand Aurora’s footprint in the Australian medical cannabis market. 

“We are deeply committed to broadening access to premium medical cannabis for the expanding community of patients who rely on Aurora, and we seek the right partners in the markets in which we operate to make this happen,” said Jerome. “Our new partnership with The Entourage Effect broadens our already robust distribution in Australia, ensuring even greater access to our high-quality medical cannabis portfolio, reinforcing our commitment to patient care.”

Aurora Cannabis brought in $81.1 million in net revenue in the three months ending September 30, 2024 (Q2 2025), and reported a net loss of nearly $13 million in the company’s most recent quarterly report. 

Just under $15.1 million of Aurora’s international sales were in the Australian market in Q2, while $20 million were in Europe and $26.3 million were in Canada.

Aurora’s major subsidies include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, Bevo Agtech Inc., CannaHealth Therapeutics Inc., and ACB Captive Insurance Company Inc.

The Entourage Effect lists several other cannabis brands under its distribution wing, including Canadian brands like Lot 420, Redecan, Tilray Medical, and Broken Coast.

Related Articles

Australian Senate rejects cannabis legalization bill

November 27, 2024

Australian cannabis companies are growing weary of Canadian imports

October 29, 2024

International medical cannabis market driving Aurora’s cannabis sales

August 10, 2023